The accepted mechanism of STAT activation involves its phosphorylation by a ligand-activated tyrosine kinase, which induces STAT dimerisation and its nuclear entry. Now, though, Jeffrey Williams and colleagues reveal that STAT activation - an important regulator of gene expression - can be driven by phosphatase inhibition rather than just by kinase activation. In Dictyostelium, they report, the prestalk cell inducer DIF-1 activates STATc by inhibiting the protein tyrosine phosphatase PTP3 (see p. 1347). DIF-1 controls the differentiation of certain prestalk cells by inducing the nuclear localisation of STATc in these cells. The researchers show that PTP3 interacts directly with STATc and that its inhibition causes the constitutive tyrosine phosphorylation of STATc and its nuclear localisation throughout the developing slug. The treatment of developing Dictyostelium cells with DIF-1 or their exposure to hyper-osmotic shock (which also induces STATc nuclear localisation) reduces PTP3's activity; significantly, both treatments induce the serine-threonine phosphorylation of PTP3. Together, these results provide important new insights into STAT activation.
STAT activation: DIF-ining a new mechanism
STAT activation: DIF-ining a new mechanism. Development 1 April 2008; 135 (7): e705. doi:
Download citation file:
Advertisement
Cited by
Pathway to Independence programme

We’re excited to announce our new Pathway to Independence programme, aimed at supporting postdocs as they go on the job market. Find out more about the scheme in our Editorial.
Call for papers: Metabolic and Nutritional Control of Development and Regeneration

We are welcoming submissions for our next special issue, which will focus on metabolic and nutritional control of development and regeneration. Submission deadline: 15 May 2023.
Webinar: Increasing the visibility and impact of your research
-HUBSwebinar.jpg?versionId=4486)
Would you like to increase the visibility and impact of your research and raise your profile internationally? If so, register for the very practical webinar we are running in association with HUBS on 23 February 2023.
Transitions in development: Daniel Grimes

Daniel Grimes’s lab studies the consequences of ciliary mutations, including left-right patterning defects and scoliosis. We interviewed Daniel to find out more about his career path, his experience of becoming a group leader and the influence of Jurassic Park.
Preprints in Development
(update)-InPreprints.png?versionId=4486)
As part of our efforts to support the use of preprints and help curate the preprint literature, we are delighted to launch a new article type: ‘In preprints’. These pieces will discuss one or more recent preprints and place them in a broader context.